These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15720269)

  • 1. The agony and ecstasy of "OMIC" technologies in drug development.
    Bilello JA
    Curr Mol Med; 2005 Feb; 5(1):39-52. PubMed ID: 15720269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do 'omic technologies have to offer periodontal clinical practice in the future?
    Grant MM
    J Periodontal Res; 2012 Feb; 47(1):2-14. PubMed ID: 21679186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New omics information for clinical trial utility in the primary setting.
    Damia G; Broggini M; Marsoni S; Venturini S; Generali D
    J Natl Cancer Inst Monogr; 2011; 2011(43):128-33. PubMed ID: 22043059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fulfilling the promise: drug discovery in the post-genomic era.
    Chanda SK; Caldwell JS
    Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel biomedicine based on genome science.
    Baba Y
    Eur J Pharm Sci; 2001 Apr; 13(1):3-4. PubMed ID: 11292562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics in biomarker discovery and drug development.
    He QY; Chiu JF
    J Cell Biochem; 2003 Aug; 89(5):868-86. PubMed ID: 12874822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies in drug discovery.
    Ohlstein EH; Johnson AG; Elliott JD; Romanic AM
    Methods Mol Biol; 2006; 316():1-11. PubMed ID: 16671397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protozoan genomics for drug discovery.
    Chaudhary K; Roos DS
    Nat Biotechnol; 2005 Sep; 23(9):1089-91. PubMed ID: 16151400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and proteomics in process development: opportunities and challenges.
    Gupta P; Lee KH
    Trends Biotechnol; 2007 Jul; 25(7):324-30. PubMed ID: 17475353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Omics Data Can Be Used in Nephrology.
    Rhee EP
    Am J Kidney Dis; 2018 Jul; 72(1):129-135. PubMed ID: 29478865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
    Aardema MJ; MacGregor JT
    Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-omic analysis of human naïve CD4+ T cells.
    Mitchell CJ; Getnet D; Kim MS; Manda SS; Kumar P; Huang TC; Pinto SM; Nirujogi RS; Iwasaki M; Shaw PG; Wu X; Zhong J; Chaerkady R; Marimuthu A; Muthusamy B; Sahasrabuddhe NA; Raju R; Bowman C; Danilova L; Cutler J; Kelkar DS; Drake CG; Prasad TS; Marchionni L; Murakami PN; Scott AF; Shi L; Thierry-Mieg J; Thierry-Mieg D; Irizarry R; Cope L; Ishihama Y; Wang C; Gowda H; Pandey A
    BMC Syst Biol; 2015 Nov; 9():75. PubMed ID: 26542228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.